Austin, Texas 11/20/2007 12:01:52 AM
Speak with other shareholders about: (Nasdaq: GNLB), (Nasdaq: ULBI), (Nasdaq: NITE)
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.
----------------------------------------------------------
Chat real-time with other investors about this GNLB news release,
by clicking this link: http://www.stockwire.com/GNLB
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=GNLB
Genelabs Technologies (Nasdaq: GNLB) Closed at $1.69. Today announced that it has regained full development and licensing rights in Japan for its investigational lupus drug Prestara (GL701), under the terms of a termination agreement between the Company and Mitsubishi Tanabe Pharma Corporation.
Genelabs and Tanabe Seiyaku Co., Ltd., a predecessor company to Mitsubishi Tanabe Pharma Corporation, signed their collaboration and license agreement in January 2004. The agreement provided that Tanabe was responsible for conducting all development work and obtaining regulatory approval for Prestara(TM) in Japan.
----------------------------------------------------------
Chat real-time with other investors about this ULBI news release,
by clicking this link: http://www.stockwire.com/ULBI
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=ULBI
Ultralife Batteries (Nasdaq: ULBI) Closed at $13.69. Today announced it has completed the acquisitions of Stationary Power Services, Inc., and Reserve Power Systems, Inc., effective November 16. Under the terms of the Stationary Power Services agreement, the purchase price consisted of $6 million in cash, a $4 million non-transferable subordinated convertible note held by the seller and a performance-based equity incentive payable in up to 100,000 unregistered shares of Ultralife common stock over a period of up to five years.
The $4 million convertible note carries a three-year term and is convertible into shares of Ultralife common stock at the rate of $15.00 per share, with a forced conversion feature at $17.00 per share. Management anticipates that the transaction will be accretive in the first quarter of 2008. The company used a portion of the net proceeds from a $13.5 million limited public offering completed on November 16 to finance the $6 million cash component of the purchase price.
----------------------------------------------------------
Chat real-time with other investors about this NITE news release,
by clicking this link: http://www.stockwire.com/NITE
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=NITE
Knight Capital Group (Nasdaq: NITE) Closed at $13.04. Today announced that it has agreed to acquire EdgeTrade Inc., a leading agency-only trade execution and algorithmic software firm, for approximately $29.5 million of cash and 2.3 million shares of unregistered Knight stock, subject to adjustment based on Knight's stock price prior to closing and the working capital of EdgeTrade at the closing.
--------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
